CALGARY, April 23, 2019 /CNW/ – Pond Technologies Holdings Inc. (“Pond”) (TSX.V: POND) is pleased to announce that Pond Naturals,, its wholly owned subsidiary, has expanded its line of algae-based consumer products. Its new X10 brand ( is focused on improving pet health and formulated to serve the premium pet supplement marketplace. 

The launch of X10 marks the achievement of another milestone as Pond executes its plan to pursue vertical integration for high-value algae products.  X10 uses algae oil containing astaxanthin that is produced at Pond Naturals’ algae plant in Agassiz, British Columbia. Along with Regenurex, Pond’s astaxanthin brand aimed at improving human health, X10 provides Pond Naturals Agassiz facility with a second brand platform to commercially leverage.  As Pond continues to introduce technology to increase astaxanthin production, X10 represents another opportunity to capture higher margins from branded consumer products.

Studies support astaxanthin supplements (also marketed as “red algae” in the skincare industry) as beneficial for humans and animals alike. The X10 product is designed to benefit ten aspects of a pet’s health by reducing free radical damage which may promote recovery and slow down the natural effects of aging on the body.

Curtis Braun, Pond Naturals CEO, commented,

“The X10 brand launch demonstrates Pond’s commitment to capturing margins through vertical integration while providing consumers with premium, Made-in-Canada health products.” 

X10 was developed by Regenurex Health Corporation (acquired by Pond Naturals in January) in close partnership with Odorchem Manufacturing Corporation (“Odorchem”). Odorchem is an established manufacturer of natural formula-based odour neutralizers, and has existing distribution channels in the North American pet market. X10 is already being carried by Maddies Natural Pet Products and Kane Veterinary Supplies in Canada with US and UK distribution partners expected to join soon. The partnership with Odorchem allows Pond Naturals to derive synergies from established distribution channels into brick-and-mortar retailers, while building on the Regenurex e-commerce platform for online sales (

Shane Lander, Odorchem CEO, remarked,

“We are excited to partner with Pond to launch this brand. We have tested various trial formulations on our dogs for several years and have witnessed positive results. I’m confident that Odorchem’s reputation and knowledge of the pet supplement industry can greatly accelerate market entry. We have seen a big uptake in demand for premium pet supplements and view the North American market as underserved.”



About Pond Technologies:


Located in Markham, Ontario, Pond is a technology company that provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond’s proprietary growth platform, including patented advanced photonics, optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms. This enables industrial emitters to generate new revenue streams from the transformation of underutilized CO2 to valuable algae-based products, such as protein for animal feed and nutraceutical products like Chlorella, Spirulina, and Astaxanthin for human or pet consumption.




About Odorchem Manufacturing:


Odorchem Manufacturing Corporation produces high quality non-toxic odour control solutions for industrial, commercial and residential applications. Odorchem’s industrial strength odour neutralizers utilize only the highest quality essential oils blended into a proprietary formulation which neutralizes a wide spectrum of both organic and inorganic odours. Odorchem’s formulas have been proven effective over 22 years in industrial odour removal; they destroy odours at a molecular level rather than simply masking them. Odorchem’s mission is to produce powerful, scientifically engineered odour neutralizing chemicals that are safe for use around people, pets and the environment.


Forward Looking Statements


This news release contains forward-looking statements within the meaning of applicable securities laws, including statements identified by words such as “focused”, “plan”, “aimed”, “opportunity”, “designed”, “expected”, or similar expressions and includes suggestions of future outcomes, including statements about: plans to pursue vertical integration for high-value algae products; the ability to capture margins through vertical integration; the ability to commercially leverage its facility; the introduction of technology to increase astaxanthin production; the benefit designs of X10 and the ability to capture higher margins from branded consumer products. Although Pond believes that the expectations represented by such forward-looking statements are reasonable, there can be no assurance that such expectations will provide to be correct. Readers are cautioned not to place undue reliance on forward-looking statements as actual results may differ materially from those expressed or implied. The factors or assumptions on which the forward-looking statements are based include: the ability to commercialize product at current facilities; the ability to secure appropriate funding or financing; stable or increasing demand for premium consumer products; and the ability to access and implement the technology necessary to achieve expected future results.


See for a summary of condition-specific scientific studies relating to astaxanthin extracted from microalgae.



Additional information about risks, assumptions, uncertainties and other factors that could influence Pond’s business is provided in Pond’s most recent Management’s Discussion & Analysis, available on SEDAR at and on Pond’s website.


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved of the information contained herein.




SOURCE Pond Technologies Holdings Inc.


For further information:


Steve Martin, Chief Executive Officer, at, 416-287-3835 ext. 201


Chris Cory, Investor Relations, at, 416‐287‐3835 ext. 215




This article was previously released via Newswire.